These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Calcium and vitamin D protect against osteoporosis fractures]. Lüllmann H Dtsch Med Wochenschr; 1996 Mar; 121(11):356-7. PubMed ID: 8681728 [No Abstract] [Full Text] [Related]
9. [Basic therapy of osteoporosis in the elderly. Interview by Dr. rer. nat. Till Uwe Keil]. Minne W Fortschr Med; 1995 Sep; 113(25):48. PubMed ID: 7498851 [No Abstract] [Full Text] [Related]
10. Vertebral spine osteoporosis treatment efficacy in local population: A clinical study. Asadullah M; Ikram R; Qazi S Pak J Pharm Sci; 2018 Nov; 31(6):2347-2353. PubMed ID: 30473503 [TBL] [Abstract][Full Text] [Related]
11. [Guideline stipulated treatment with calcium and vitamin D. Not even every third osteoporosis patient receives them]. Fischer M MMW Fortschr Med; 2006 Jun; 148(22):50. PubMed ID: 16821582 [No Abstract] [Full Text] [Related]
12. [Nutrition and osteoporosis. When is a supplementation with calcium and vitamin D3 useful?]. Kraenzlin M Ther Umsch; 2005 Dec; 62(12):796. PubMed ID: 16405282 [No Abstract] [Full Text] [Related]
13. [Osteoporosis. How long should it be treated?]. Stiefelhagen P MMW Fortschr Med; 2002 Nov; 144(47):12. PubMed ID: 12532515 [No Abstract] [Full Text] [Related]
16. [How much calcium and vitamin D are really necessary]. Brettschneider H MMW Fortschr Med; 2009 Apr; 151(16):18-9. PubMed ID: 19658290 [No Abstract] [Full Text] [Related]
17. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front]. MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198 [No Abstract] [Full Text] [Related]
18. [Osteobor forte--rational solution in fight against osteoporosis]. Petrova I Akush Ginekol (Sofiia); 2003; 42 Suppl 2():39-40. PubMed ID: 14619756 [No Abstract] [Full Text] [Related]
19. [What is reliable in drug therapy of osteoporosis?]. Friebe H Z Orthop Ihre Grenzgeb; 2001; 139(2):M25-6. PubMed ID: 11386115 [No Abstract] [Full Text] [Related]
20. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis. Voskaridou E; Christoulas D; Antoniadou L; Terpos E Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025 [No Abstract] [Full Text] [Related] [Next] [New Search]